New Postings on the Reed Smith Health Industry Washington Watch Blog
The Reed Smith Health Industry Washington Watch blog has been updated to discuss a variety of health policy developments, including the following:
- Regulatory Developments. HHS has posted its latest regulatory agenda, and rule standards for health care electronic funds transfers, and FDA has announced an opportunity for public comment on its Healthcare Professional Survey of Prescription Drug Promotion. CMS has published rules on payments to retiree prescription drug plan sponsors and changes to Medicaid disproportionate share hospital payments.
- Other HHS Developments. HHS has revised contraception coverage rules for certain religious groups offering insurance. CMS has established procedures for claims against DMEPOS surety bonds, and has released information on Medicaid drug pricing, Medicare Part D drug plan reporting, and national health care spending. FDA has released information on drug user fees and advertising and promotional labeling.
- Legislative Developments. The House is considering legislation to repeal the ACA CLASS program, and a House panel is planning hearings on FDA user fees.
- OIG & GAO Developments. Recent OIG reports have addressed hospital incident reporting systems and Medicare Part B drug pricing. The OIG also has released new compliance training video and audio presentations. A GAO report examines prescription pain reliever abuse.
- Odds & Ends. The Patient-Centered Outcomes Research Institute (PCORI) has released its draft National Priorities for Research and Research Agenda, and the CBO has examined options for raising the Medicare eligibility age.
- Health Industry Events. CMS is hosting a Medicare Shared Savings/ACO Program Webinar and a meeting of the Advisory Panel on Hospital Outpatient Policy.
